Direct and indirect effects of insulin on hepatic glucose production in diabetic depancreatized dogs during euglycemia

Journal of Endocrinology

Volumn 190, Issue 3, 2006, Pages 695-702

  Gupta, Neehar ^a   Park, Edward ^a   Sandhu, Harmanjit ^a   Goh, Tracy ^a   Tchipashvili, Vaja ^a   Giacca, Adria ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOG; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPOTHESIS; INSULINEMIA; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DOGS; GLUCOSE; INSULIN; LIVER; LIVER CIRCULATION; MALE; MODELS, ANIMAL; PANCREATECTOMY;

EID: 33749833743     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06443     Document Type: Article

References (26)

1. Ader M & Bergman RN 1990 Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. American Journal of Physiology 258 E1020-E1032.
2. Bjorkman O, Miles P, Wasserman D, Lickley L & Vranic M 1988 Regulation of glucose turnover during exercise in pancreatectomized, totally insulin-deficient dogs. Effects of beta-adrenergic blockade. Journal of Clinical Investigation 81 1759-1767.
3. Bradley DC, Steil GM & Bergman RN 1993 Quantitation of measurement error with optimal segments: basis for adaptive time course smoothing. American Journal of Physiology 264 E902-E911.
4. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S & Lupien PJ 1996 Hyperinsulinemia as an independent risk factor for ischemic heart disease. New England Journal of Medicine 334 952-957.
5. Edgerton DS, Lautz M, Scott M, Everett CA, Stettler KM, Neal DW, Chu CA & Cherrington AD 2006 Insulin's direct effects on the liver dominate the control of hepatic glucose production. Journal of Clinical Investigation 116 521-527.
6. Finegood DT, Bergman RN & Vranic M 1987 Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36 914-924.
7. Giacca A, Fisher SJ, Shi ZQ, Gupta R, Lickley HL & Vranic M 1992 Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs. Journal of Clinical Investigation 90 1769-1777.
8. Giacca A, Fisher SJ, McCall RH, Shi ZQ & Vranic M 1997 Direct and indirect effects of insulin in suppressing glucose production in depancreatized dogs: role of glucagon. Endocrinology 138 999-1007.
9. Giacca A, McCall R, Chan B & Shi ZQ 1999 Increased dependence of glucose production on peripheral insulin in diabetic depancreatized dogs. Metabolism 48 153-160.
10. Giovannucci E 2001 Insulin, insulin-like growth factors and colon cancer: a review of the evidence. Journal of Nutrition 131 3109S-3120S.
11. Gupta N, Sandhu H, Goh T, Shah K, Wiesenthal SR, Yoshii H, Chong V, Lam TK, Haber CA, Williams W et al. 2002 Insulin inhibits glucose production by a direct effect in diabetic depancreatized dogs during euglycemia. American Journal of Physiology, Endocrinology and Metabolism 283 E1002-E1007.
12. Kadish AH & Sternberg JC 1969 Determination of urine glucose by measurement of rate of oxygen consumption. Diabetes 18 467-470.
13. Lewis GF, Zinman B, Groenewoud Y, Vranic M & Giacca A 1996 Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Diabetes 45 454-462.
14. Lewis GF, Carpentier A, Vranic M & Giacca A 1999 Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes. Diabetes 48 570-576.
15. Mason TM, Gupta N, Goh T, El Bahrani B, Zannis J, van de Werve G & Giacca A 2000 Chronic intraperitoneal insulin delivery, as compared with subcutaneous delivery, improves hepatic glucose metabolism in streptozotocin diabetic rats. Metabolism 49 1411-1416.
16. McCall RH, Wiesenthal SR, Shi ZQ, Polonsky K & Giacca A 1998 Insulin acutely suppresses glucose production by both peripheral and hepatic effects in normal dogs. American Journal of Physiology 274 E346-E356.
17. Miles J, Glasscock R, Aikens J, Gerich J & Haymond M 1983 A microfluorometric method for the determination of free fatty acids in plasma. Journal of Lipid Research 24 96-99.
18. Obici S, Zhang BB, Karkanias G & Rossetti L 2002 Hypothalamic insulin signaling is required for inhibition of glucose production. Nature Medidne 8 1376-1382.
19. Prager R, Wallace P & Olefsky JM 1987 Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects. Diabetes 36 607-611.
20. Radziuk J & Lickley HL 1985 The metabolic clearance of glucose: measurement and meaning. Diabetologia 28 315-322.
21. Rossetti L, Giaccari A, Barzilai N, Howard Y, Sebel G & Hu M 1993 Mechanism by which hyperglycemia. inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes. Journal of Clinical Investigation 92 1126-1134.
22. Sindelar DY, Balcom JH, Chu CA, Neal DW & Cherrington AD 1996 A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog. Diabetes 45 1594-1604.
23. Sindelar DY, Chu CA, Neal DW & Cherrington AD 1997 Interaction of equal increments in arterial and portal vein insulin on hepatic glucose production in the dog. American Journal of Physiology 273 E972-E980.
24. Sindelar DK, Chu CA, Venson P, Donahue EP, Neal DW & Cherrington AD 1998 Basal hepatic glucose production is regulated by the portal vein insulin concentration. Diabetes 47 523-529.
25. Staehr P, Hother-Nielsen O, Levin Y, Holst JJ & Beck-Nielsen H 2001 Assessment of hepatic insulin action in obese type 2 diabetic patients. Diabetes 50 1363-1370.
26. Wan CK, Giacca A, Matsuhisa M, El Bahrani B, Lam L, Rodgers C & Shi ZQ 2000 Increased responses of glucagon and glucose production to hypoglycemia with intraperitoneal versus subcutaneous insulin treatment. Metabolism 49 984-989.